在资源有限的环境中，最佳的一线抗逆转录病毒治疗方案是什么？
What is the optimal first line antiretroviral therapy in resource-limited settings?
机构信息
Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Observatory, Cape Town, South Africa.
出版信息
PLoS Med. 2012;9(8):e1001291. doi: 10.1371/journal.pmed.1001291. Epub 2012 Aug 14.
Abstract
A perspective by Chris Kenyon and Robert Colebunders discusses policy implications for use of first line antiretroviral therapies in resource-limited settings, emerging from a new research study conducted by Campbell and colleagues.
摘要
克里斯·肯扬和罗伯特·科尔本德斯的观点探讨了在资源有限的环境中使用一线抗逆转录病毒疗法的政策影响，这是由坎贝尔及其同事进行的一项新研究得出的。
相似文献
1
What is the optimal first line antiretroviral therapy in resource-limited settings?在资源有限的环境中，最佳的一线抗逆转录病毒治疗方案是什么？
PLoS Med. 2012;9(8):e1001291. doi: 10.1371/journal.pmed.1001291. Epub 2012 Aug 14.
2
[HIV and pregnancy].[艾滋病毒与妊娠]
MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:63-5.
3
[Highly active initial therapy without resistance development. Even after 6 years still effective HIV therapy].[高效初始治疗且无耐药性产生。即使6年后HIV治疗仍有效]
MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:54-5.
4
"Solving the puzzle" of current HAART: what key strategic trials are needed?破解当前高效抗逆转录病毒疗法的“谜题”：需要哪些关键的战略试验？
New Microbiol. 2004 Apr;27(2 Suppl 1):127-30.
5
Editorial comment: treatment of acute HIV infection--uncertainties about best practice.编辑评论：急性HIV感染的治疗——最佳实践的不确定性
AIDS Read. 2005 May;15(5):250-1.
6
Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.柬埔寨感染 HIV 患者接受抗逆转录病毒治疗 4 年后的免疫病毒学结果和耐药模式。
Trop Med Int Health. 2011 Feb;16(2):205-13. doi: 10.1111/j.1365-3156.2010.02689.x. Epub 2010 Nov 19.
7
[HIV eradication--facts and fiction].[消除艾滋病病毒——事实与虚构]
MMW Fortschr Med. 2008 Apr 28;150 Spec No 1:72-3.
8
Development of gynecomastia following initiation of bictegravir/emtricitabine/tenofovir alafenamide.比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺起始治疗后男性乳房发育症的发生
Int J STD AIDS. 2020 Mar;31(4):380-382. doi: 10.1177/0956462419895665. Epub 2020 Feb 10.
9
Treating primary HIV infection--is your HAART in it?治疗原发性HIV感染——你的高效抗逆转录病毒疗法参与其中了吗？
Sex Health. 2004;1(3):131-5. doi: 10.1071/sh04017.
10
HIV and Aging in the Era of ART and COVID-19: Symposium Overview.抗逆转录病毒治疗与新冠疫情时代的HIV与衰老：研讨会概述
J Acquir Immune Defic Syndr. 2022 Feb 1;89(Suppl 1):S3-S9. doi: 10.1097/QAI.0000000000002837.
引用本文的文献
1
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?国际强制许可能否使药品分级定价与健康权相协调？
BMC Int Health Hum Rights. 2014 Dec 18;14:37. doi: 10.1186/s12914-014-0037-4.
本文引用的文献
1
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.三种抗逆转录病毒方案治疗 HIV-1 初治的疗效和安全性：多种族多国环境下的随机临床试验。
PLoS Med. 2012;9(8):e1001290. doi: 10.1371/journal.pmed.1001290. Epub 2012 Aug 14.
2
Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America.分配稀缺的财务资源用于 HIV 治疗：拉丁美洲抗逆转录病毒药物价格的基准比较。
Health Policy Plan. 2012 Dec;27(8):638-48. doi: 10.1093/heapol/czs011. Epub 2012 Feb 24.
3
Pre-ART HIV resistance testing in Africa: are we there yet?非洲抗逆转录病毒治疗前的艾滋病毒耐药性检测：我们做到了吗？
Lancet Infect Dis. 2012 Apr;12(4):261. doi: 10.1016/S1473-3099(11)70280-8. Epub 2011 Oct 27.
4
Prevention of HIV-1 infection with early antiretroviral therapy.早期抗逆转录病毒疗法预防 HIV-1 感染。
N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.
5
Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho.在莱索托农村资源有限的环境下，将 d4T 或 AZT 转换为 TDF 为基础的一线方案的成本和成本效益。
J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):e68-74. doi: 10.1097/QAI.0b013e31822a9f8d.
6
THE RISKS OF CONCURRENT TREATMENT WITH TENOFOVIR AND AMINOGLYCOSIDES IN PATIENTS WITH HIV-ASSOCIATED TUBERCULOSIS.HIV 相关结核病患者中同时使用替诺福韦和氨基糖苷类药物进行治疗的风险
South Afr J HIV Med. 2011;12(1):43-45. doi: 10.4102/sajhivmed.v12i1.214.
7
Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.海地 HIV 感染成人的早期与标准抗逆转录病毒治疗。
N Engl J Med. 2010 Jul 15;363(3):257-65. doi: 10.1056/NEJMoa0910370.
8
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.成人 HIV 感染的抗逆转录病毒治疗：国际艾滋病协会-美国小组 2010 年的建议。
JAMA. 2010 Jul 21;304(3):321-33. doi: 10.1001/jama.2010.1004.
9
10
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.替诺福韦酯、恩曲他滨和依非韦伦与齐多夫定、拉米夫定和依非韦伦治疗HIV的比较
N Engl J Med. 2006 Jan 19;354(3):251-60. doi: 10.1056/NEJMoa051871.
Zotero 插件